UPF0317 protein SAV_6940 can be expressed in multiple host systems, each offering distinct advantages. While Escherichia coli remains a common first choice for many recombinant proteins, alternative expression systems may yield superior results depending on your specific research requirements .
Comparative Expression Systems for UPF0317 protein SAV_6940:
| Expression Host | Advantages | Limitations | Typical Yield | Recommended Applications |
|---|---|---|---|---|
| E. coli | Lower cost, rapid growth, established protocols | Limited post-translational modifications, potential inclusion body formation | Moderate | Basic biochemical studies, structural biology |
| Yeast | More complex post-translational modifications, secretion capability | Higher cost than E. coli, longer production time | Moderate to high | Functional studies requiring eukaryotic modifications |
| Vibrio natriegens | Rapid growth (≤10 min doubling time), reduced protein aggregation, compatible with E. coli techniques | Relative sensitivity to ampicillin, specialized growth media requirements | High for certain proteins | Proteins difficult to express in E. coli, isotopically labeled proteins |
| Baculovirus/Insect | Complex post-translational modifications, high expression levels | Higher cost, longer production time | Variable | Proteins requiring complex folding or modifications |
| Mammalian cells | Native post-translational modifications, proper folding of complex proteins | Highest cost, longest production time | Low to moderate | Proteins requiring mammalian-specific modifications |
Recent studies suggest that for some recombinant proteins, V. natriegens can overcome roadblocks encountered with E. coli expression, suggesting fundamental differences in processes such as protein folding via chaperones .
Successful expression begins with effective transformation and optimized growth conditions. For challenging proteins like UPF0317 protein SAV_6940, consider these evidence-based approaches:
For E. coli-based expression:
Use BL21(DE3) or similar strains with reduced protease activity
Optimize induction conditions: typically IPTG at 0.1-1.0 mM
Consider lower temperature induction (16-20°C) to enhance protein folding
Test auto-induction media for higher yields of some proteins
For V. natriegens-based expression:
Use reduced ampicillin concentration (5 μg/mL initially, then 50 μg/mL for subsequent growth) to overcome higher sensitivity compared to E. coli
Prepare higher density competent cells to improve transformation efficiency
Modify transformation protocols by eliminating secondary heat shock steps and shortening grow-out times to 1 hour
Consider maintaining cultures at 30°C rather than lower temperatures, as lower temperatures may reduce recombinant expression in V. natriegens
Purification strategy depends on expression system and fusion tags incorporated into your construct. Based on experimental data with similar proteins, we recommend:
Initial capture: Immobilized metal affinity chromatography (IMAC) for His-tagged constructs
Intermediate purification: Tag cleavage using TEV protease
Polishing step: Size exclusion chromatography (SEC)
Key considerations:
Expression in different hosts may affect purification outcomes; protein from V. natriegens has shown higher proportion of properly folded protein for some targets compared to E. coli
Monitor for common contaminants - when expressed in E. coli, recombinant proteins may co-purify with ArnA (~75 kDa contaminant in IMAC)
SEC profiles can indicate protein quality - properly folded proteins typically elute in the expected molecular weight range, while aggregates elute in the void volume
Research suggests fundamental differences in protein folding between expression systems, with significant implications for research outcomes:
Case study evidence from similar proteins:
Small GTPase KRAS4b expressed in V. natriegens showed almost complete digestion by TEV protease and monomeric behavior on SEC, indicating proper folding
The same protein expressed in E. coli exhibited partial resistance to TEV protease and contained soluble aggregates, suggesting incomplete folding
RAF1 kinase CR1 domain showed improved thermal stability (measurable Tm of 72-74°C) when expressed in V. natriegens versus unmeasurable Tm for E. coli-expressed protein
This suggests that while E. coli may produce higher total amounts of soluble fusion protein, V. natriegens may produce a higher proportion of correctly folded protein leading to better final yields of functional protein .
Hypothesized mechanisms for these differences include:
Differences in chaperone availability or activity
Variation in cytoplasmic redox environment
Differences in translation rates affecting co-translational folding
Isotopic labeling is essential for NMR studies and can enhance mass spectrometry analyses. Based on experimental findings with other recombinant proteins:
Optimization strategies for isotopic labeling:
For UPF0317 protein SAV_6940, V. natriegens expression may be particularly valuable if the protein proves challenging to express in E. coli, as it can provide sufficient material for structural biology applications that would otherwise be unaffordable or impossible to produce .
Multiple complementary techniques should be employed to fully characterize recombinant UPF0317 protein:
Recommended analytical cascade:
SDS-PAGE/Coomassie staining: Initial purity assessment (target >95% purity)
Size Exclusion Chromatography (SEC): Evaluate oligomeric state and aggregation
Mass Spectrometry:
Intact mass analysis: Verify protein identity and post-translational modifications
Peptide mapping: Confirm sequence coverage and identify modifications
Thermal stability assessment:
Functional assays:
Activity tests specific to the protein class
Binding assays if interaction partners are known
When comparing expression systems, these analytical techniques can reveal important differences in protein quality. For example, the SEC profile can indicate if the protein elutes as expected for its molecular weight or shows signs of aggregation or interaction with the column matrix, as observed with some nanobodies expressed in different systems .
While specific functional data for UPF0317 protein SAV_6940 is limited, bioinformatic approaches can provide insights:
Sequence homology: Analysis of conserved domains may reveal relationships to characterized protein families
Structural prediction: Tools like AlphaFold can predict 3D structure to suggest functional sites
Genomic context: Examining neighboring genes may indicate involvement in specific pathways
Comparative expression analyses: Transcriptomic data might reveal co-expression patterns suggesting functional relationships
A differentially expressed gene analysis mentioned in search results identified UPF0317 protein SAV_6940 (comp103200_c0_seq1) with a fold change of 4.88 (p=0.03) , suggesting potential biological significance under specific conditions.
Construct design significantly impacts expression success. Consider these evidence-based approaches:
Key design elements:
Vector selection: pET-series vectors work well in both E. coli and V. natriegens
Fusion tags:
Codon optimization: Adapt to the expression host of choice
Regulatory elements: Strong promoters (T7) for high expression, weaker promoters if toxicity is observed
Construct evaluation strategies:
Test multiple constructs in parallel small-scale expressions
Compare different fusion partners' effects on solubility
Evaluate the impact of N- versus C-terminal tags
For expression in V. natriegens, constructs developed for E. coli can often be used directly, but consider ampicillin resistance issues noted earlier .
Scaling from small test expressions to larger preparations requires careful optimization:
Critical parameters for scale-up:
The faster growth rate of V. natriegens (≤10 min doubling time) allows generation of cell pellets within 24 hours from seed culture inoculation, substantially improving laboratory throughput compared to typical E. coli processes .
Based on experience with similar proteins, here are solutions to common challenges:
Troubleshooting guide:
When encountering difficulty with expression in E. coli, consider V. natriegens as an alternative, particularly for proteins that form inclusion bodies or show poor folding .
Recent advances are expanding options for challenging protein expression:
Cell-free protein synthesis systems:
Eliminate cell viability constraints
Rapid production (hours versus days)
Easily incorporate non-canonical amino acids
Engineered expression hosts:
AI-assisted protein design:
Improved prediction of solubility-enhancing mutations
Optimization of constructs for specific expression systems
High-throughput screening platforms:
Parallel testing of multiple expression constructs
Automated purification and analysis
These technologies are particularly valuable for structurally complex or poorly characterized proteins like UPF0317 SAV_6940, where traditional approaches may yield insufficient material for advanced structural and functional studies.
While specific functions of UPF0317 protein SAV_6940 remain to be fully characterized, research on this protein contributes to several important scientific areas:
Methodological advances in protein production:
Bacterial physiology:
Understanding UPF0317 protein SAV_6940 may reveal aspects of bacterial adaptation mechanisms
Comparative studies between different bacterial species expressing homologous proteins can illuminate evolutionary relationships
Structural biology:
Novel protein structures expand our understanding of protein folding and function
May reveal previously uncharacterized protein folds or functional motifs
Potential biotechnological applications:
If functional characterization reveals enzymatic activity, potential applications in biocatalysis
Understanding protein folding differences between expression systems has broad implications for recombinant protein production technologies
This research exemplifies how studies of individual proteins contribute to both fundamental understanding of biological systems and practical advances in biotechnology methodologies.